Empagliflozin improves primary haemodynamic parameters and attenuates the development of atherosclerosis in high fat diet fed APOE knockout mice
Author:
Funder
Novo-Nordisk Hellas
Publisher
Elsevier BV
Subject
Endocrinology,Molecular Biology,Biochemistry
Reference50 articles.
1. Empagliflozin, calcium, and SGLT1/2 receptor affinity: another piece of the puzzle;Anker;ESC Heart Fail,2018
2. Glycemic control by the SGLT2 inhibitor empagliflozin decreases aortic stiffness, renal resistivity index and kidney injury;Aroor;Cardiovasc. Diabetol.,2018
3. Effects of sodium-glucose co-transporter 2 inhibitors on blood pressure: a systematic review and meta-analysis;Baker;J. Am. Soc. Hypertens.,2014
4. Mechanism of increased LDL (Low-Density lipoprotein) and decreased triglycerides with SGLT2 (Sodium-Glucose cotransporter 2) inhibition;Basu;Arterioscler. Thromb. Vasc. Biol.,2018
5. Diabetes Medications for Adults with Type 2 Diabetes: an Update [Internet];Bolen,2016
Cited by 32 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. SGLT2 Inhibitors in Aging-Related Cardiovascular Disease: A Review of Potential Mechanisms;American Journal of Cardiovascular Drugs;2023-08-24
2. Empagliflozin reduces neointimal formation and vascular smooth muscle cell proliferation via the suppression of PDGF-related signaling;2023-08-15
3. Atherosclerotic and Cardio-Metabolic Diseases: From Molecular Basis to Therapeutic Advances;International Journal of Molecular Sciences;2023-06-04
4. The Role of Sodium-Glucose Cotransporter-2 Inhibitors in Heart Failure Management: The Continuing Challenge of Clinical Outcome Endpoints in Heart Failure Trials;Pharmaceutics;2023-03-29
5. Unlocking the Full Potential of SGLT2 Inhibitors: Expanding Applications beyond Glycemic Control;International Journal of Molecular Sciences;2023-03-23
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3